Wednesday 6 December 2017 photo 12/15
|
Eudract guidelines for colonoscopy: >> http://wzh.cloudz.pw/download?file=eudract+guidelines+for+colonoscopy << (Download)
Eudract guidelines for colonoscopy: >> http://wzh.cloudz.pw/read?file=eudract+guidelines+for+colonoscopy << (Read Online)
eudract number request
eudract requirements
eudract disclosure
eudract test
eudract annex 1
eudract results posting
eudract phase 1
eudract number vs ind number
EudraCT Number: 2010-019140-39, Sponsor Protocol Number: CPP-450, Start Date*: 2010-09-06. Sponsor Name:Centre Paul Papin. Full Title: Interet d'un traitement par cyclines dans la prevention de la toxicite cutanee du Cetuximab lors de son association a un FOLFIRI intensifie chez des patients avec un cancer
Plain English Summary EudraCT number Time To Progression with death as a competing risk will be measured as the time in days from randomisation until disease progression as determined by RECIST criteria for radiological imaging and clinical assessment 3. Progression Free Survival will be measured as the time
EudraCT Number: 2012-003342-33, Sponsor Protocol Number: STH16359, Start Date*: 2012-09-28. Sponsor Full Title: Optimising the use of Entonox during screening colonoscopy: an open randomised controlled trial. Medical . Medical condition: Patients with indications to undergoing a complete colonoscopy
3508. Background: We conducted a phase II of trastuzumab (T) and lapatinib (L) in HER2-amplified, KRAS exon 2 wild-type, mCRC pts resistant to standard therapies (HERACLES Trial EudraCT 2012-002128-33). Methods: Pts progressing after fluoropyrimidines, oxaliplatin, irinotecan, bevacizumab, cetuximab or
The different alternatives used since 1996 to treat metastatic colorectal cancer (MCRC) have increased the mean survival of these patients. This outstanding advance is due to the extended indications for resection of hepatic metastases and to the use of new chemotherapeutic drugs (fluoropyrimidine, irinotecan and
5 Jun 2017 For more information on legal requirements click here. Additionally you can find a list of the National Competent Authorities here. 14. Where is the list of protocol related fields (CTA/third country form) to be made public in EU-CTR? Please note that the list of fields to be public in the European Clinical Trials
EudraCT Number: 2007-001287-75, Sponsor Protocol Number: CPP-340, Start Date*: 2007-06-11. Sponsor Name:CENTRE PAUL PAPIN - IRCAM. Full Title: Proteomic and genetic analysis of neurotoxicity predicting markers in oxaliplatine treated patients with colorectal carcinoma. Medical condition: Colorectal cancer
16 Dec 2014 Given the potential synergy of CAPTEM combination in mCRC, we planned a randomized phase II study of second-line CAPTEM vs FOLFIRI after failure of prior first-line oxaliplatin-based treatment in patients with advanced, MGMT methylated, RAS mutated CRC (Eudract n 2014-002417-36). The primary
11 Jan 2011 Eudract Number: 2007-004539-44. SEQUENTIAL 20.2 OTHER INCLUSION CRITERIA ONLY FOR PATIENTS PREVIOUSLY ENROLLED ONTO ARM B OF THE IRST 153. 01/01 STUDY. At the end of the 1990s, two new drugs were introduced for the treatment of colon cancer: irinotecan (Campto®)
5 Jun 2017 Results FAQs. 1. Am I required to post clinical trial results at this stage? The European Commission has published guidance which describes the inclusion of clinical trial results and can be found here:Commission Guideline — Guidance on posting and publication of result-related information on clinical
Annons